Home » Stocks » KRMD

Repro-Med Systems, Inc. (KRMD)

Stock Price: $5.14 USD -0.29 (-5.34%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
After-hours: $5.16 +0.02 (0.33%) Jan 20, 5:42 PM
Market Cap 225.87M
Revenue (ttm) 26.34M
Net Income (ttm) -457,692
Shares Out 43.91M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE 55.25
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $5.14
Previous Close $5.43
Change ($) -0.29
Change (%) -5.34%
Day's Open 5.41
Day's Range 5.12 - 5.49
Day's Volume 310,918
52-Week Range 3.78 - 12.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 week ago

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President and Chief Execut...

Zacks Investment Research - 2 months ago

Repro Med Systems (KRMD) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Business Wire - 2 months ago

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that its Board of Directors has authorized a s...

Seeking Alpha - 2 months ago

Repro Med Systems, Inc.'s (KRMD) CEO Donald Pettigrew on Q3 2020 Results - Earnings Call Transcript

Business Wire - 2 months ago

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the third quarter ended ...

Business Wire - 2 months ago

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for...

Business Wire - 5 months ago

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc.

Seeking Alpha - 5 months ago

Repro Med Systems, Inc.'s (KRMD) CEO Don Pettigrew on Q2 2020 Results - Earnings Call Transcript

Business Wire - 5 months ago

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc.

Business Wire - 5 months ago

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc.

Business Wire - 6 months ago

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical”) today announced the appointment of Josh Bennett to the newly created position...

Seeking Alpha - 7 months ago

KORU Is Getting Tailwind From A Shift Away From IV And The Pandemic

Seeking Alpha - 8 months ago

Repro Med Systems, Inc. (KRMD) CEO Don Pettigrew on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 10 months ago

KORU Medical Systems (KRMD) CEO Don Pettigrew on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 11 months ago

KORU Medical Systems Growth Is Set To Continue

About KRMD

Repro Med Systems, doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The compan... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1980
CEO
Donald B. Pettigrew
Employees
71
Stock Exchange
NASDAQ
Ticker Symbol
KRMD
Full Company Profile

Financial Performance

In 2019, KRMD's revenue was $23.16 million, an increase of 33.47% compared to the previous year's $17.35 million. Earnings were $564,349, a decrease of -38.02%.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for KRMD stock is "Buy." The 12-month stock price forecast is 11.25, which is an increase of 118.87% from the latest price.

Price Target
$11.25
(118.87% upside)
Analyst Consensus: Buy